The Community Guide

- gsearch

Search Results

Narrow Results:

2024 1
2023 1
2019 1
2015 1

Journal Article 4

1 - 4 of 4 Results

Refine Results

Refine Results:

Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study

CITE Title : Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study Personal Author(s) : Sawry, Shobna;Ayalew, Kassahun;Maimela, Gloria;Briggs-Hagen, Melissa;van Wyk-Heath, Marelize;Mthethwa, Simangele;Shai, Sannie;Mngomezulu, Nkululeko N.;Tlhowe, Lawrence;Achere-Darko, Josephine;Bedford, Jason;Martin, Catherine E.;Fairlie, Lee;Imrie, John; Published Date : 7 2024;7-2024; Source : HIV Med. 25(7):826-839 URL : https://stacks.cdc.gov/view/cdc/159349 Sawry, Shobna et al. (2024). Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study. 25(7). Sawry, Shobna et al. "Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study" 25, no. 7 (2024) Sawry, Shobna et al. "Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study" vol. 25, no. 7, 2024 Export RIS Citation Information.

:

Sawry, Shobna

;

Ayalew, Kassahun

7 2024 | HIV Med. 25(7):826-839

:

Introduction:Although dolutegravir (DTG) is deemed stable, safe, cost-effective, and clinically beneficial, it also carries the risk of side effects, ...
Biochemically confirmed smoking cessation and gestational weight gain

CITE Title : Biochemically confirmed smoking cessation and gestational weight gain Personal Author(s) : Rockhill, Karilynn M.;England, Lucinda J.;Tong, Van T.;Sharma, Andrea J.; Published Date : 6 2019;6-2019; Source : Birth. 46(2):326-334 URL : https://stacks.cdc.gov/view/cdc/159411 Rockhill, Karilynn M. et al. (2019). Biochemically confirmed smoking cessation and gestational weight gain. 46(2). Rockhill, Karilynn M. et al. "Biochemically confirmed smoking cessation and gestational weight gain" 46, no. 2 (2019) Rockhill, Karilynn M. et al. "Biochemically confirmed smoking cessation and gestational weight gain" vol. 46, no. 2, 2019 Export RIS Citation Information.

:

Rockhill, Karilynn M. ;

England, Lucinda J.

6 2019 | Birth. 46(2):326-334

:

Background:Prenatal smoking cessation has substantial health benefits for mothers and offspring, but concerns about weight gain may be a barrier to qu...
Body size throughout adult life influences postmenopausal breast cancer risk among Hispanic women: The Breast Cancer Health Disparities Study

CITE Title : Body size throughout adult life influences postmenopausal breast cancer risk among Hispanic women: The Breast Cancer Health Disparities Study Personal Author(s) : John, Esther M.;Sangaramoorthy, Meera;Hines, Lisa M.;Stern, Mariana C.;Baumgartner, Kathy B.;Giuliano, Anna R.;Wolff, Roger K.;Slattery, Martha L.; Published Date : 1 2015;1-2015; Source : Cancer Epidemiol Biomarkers Prev. 24(1):128-137 URL : https://stacks.cdc.gov/view/cdc/158000 John, Esther M. et al. (2015). Body size throughout adult life influences postmenopausal breast cancer risk among Hispanic women: The Breast Cancer Health Disparities Study. 24(1). John, Esther M. et al. "Body size throughout adult life influences postmenopausal breast cancer risk among Hispanic women: The Breast Cancer Health Disparities Study" 24, no. 1 (2015) John, Esther M. et al. "Body size throughout adult life influences postmenopausal breast cancer risk among Hispanic women: The Breast Cancer Health Disparities Study" vol. 24, no. 1, 2015 Export RIS Citation Information.

:

John, Esther M. ;

Sangaramoorthy, Meera

1 2015 | Cancer Epidemiol Biomarkers Prev. 24(1):128-137

:

BackgroundFew studies have assessed the association of body size with postmenopausal breast cancer (BC) risk in Hispanic women. Findings are inconsist...
Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide

CITE Title : Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide Personal Author(s) : Palella, Frank J.;Hou, Qingjiang;Li, Jun;Mahnken, Jonathan;Carlson, Kimberly J.;Durham, Marcus;Ward, Douglas;Fuhrer, Jack;Tedaldi, Ellen;Novak, Richard;Buchacz, Kate; Published Date : 1 01 2023;1-01-; Source : J Acquir Immune Defic Syndr. 92(1):67-75 URL : https://stacks.cdc.gov/view/cdc/175439 Palella, Frank J. et al. (2023). Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide. 92(1). Palella, Frank J. et al. "Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide" 92, no. 1 (2023) Palella, Frank J. et al. "Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide" vol. 92, no. 1, 2023 Export RIS Citation Information.

:

Palella, Frank J. ;

Hou, Qingjiang

1 01 2023 | J Acquir Immune Defic Syndr. 92(1):67-75

:

Background:The timing and magnitude of antiretroviral therapy-associated weight change attributions are unclear.Setting:HIV Outpatient Study participa...